- Home
- IQV
as 12-18-2024 4:00pm EST
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 38.1B | IPO Year: | 2013 |
| Target Price: | $256.27 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.62 | EPS Growth: | 27.98 |
| 52 Week Low/High: | $187.62 - $261.73 | Next Earning Date: | 02-12-2025 |
| Revenue: | $15,315,000,000 | Revenue Growth: | 3.10% |
| Revenue Growth (this year): | 3.66% | Revenue Growth (next year): | 4.86% |
Latest IQVIA Holdings Inc. News
IQV Breaking Stock News: Dive into IQV Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$199?
The Wall Street Journal
4 days ago
The Drugs Young Bankers Use to Get Through the Day—and Night
MT Newswires
6 days ago
Truist Trims Price Target on IQVIA Holdings to $261 From $265, Keeps Buy Rating
MT Newswires
7 days ago
TD Cowen Cuts Price Target on IQVIA Holdings to $250 From $255
MT Newswires
7 days ago
Jefferies Raises Price Target on IQVIA Holdings to $200 From $195
MT Newswires
7 days ago
Baird Trims Price Target on IQVIA Holdings to $212 From $213, Keeps Neutral Rating
MT Newswires
7 days ago
Deutsche Bank Adjusts IQVIA Holdings Price Target to $260 From $265, Maintains Buy Rating
Simply Wall St.
9 days ago
Is IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 20% Impressive?
Compare IQV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IQV IQVIA Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.